COSELA: payments to doctors
Payments that named COSELA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $1.8M
- Providers
- 5,477
- Transactions
- 13,369
- Average per transaction
- $135
The per-transaction average — $135 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,477 providers the average total is $330, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| G1 Therapeutics, Inc. | $1,471,553 | 81.4% |
| Pharmacosmos Therapeutics Inc. | $270,088 | 14.9% |
| Boehringer Ingelheim | $66,908 | 3.7% |